Skip to main content
Erschienen in: Journal of Nephrology 1/2017

01.02.2017 | Original Article

Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis

verfasst von: Duvuru Geetha, Scott M. Lee, Shivani Shah, Hafizur M. Rahman

Erschienen in: Journal of Nephrology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Renal transplantation (RTx) is the modality of choice for ESRD due to ANCA associated vasculitis (AAV). The significance of ANCA positivity (ANCA+) at the time of RTx on recurrent disease is controversial.

Methods

We evaluated clinical outcomes and predictors of vasculitis relapse in sixteen transplanted AAV patients who were ANCA+ at RTx at a single University Medical Center. Allograft function, vasculitis relapse, and predictors of vasculitis relapse were assessed using descriptive statistics and logistic regression analysis.

Results

Our cohort had a median age of 64 years, 88 % Caucasians, 63 % males, 50 % PR3+. All patients were in remission at the time of RTx. Twelve received induction therapy and all were on mycophenolate mofetil, prednisone and tacrolimus. The mean (SD) serum creatinine was 1.2 (0.3) mg/dl at 1 year and 1.8 (1.7) mg/dl at last follow up. Six developed vasculitis relapse at post-transplant. All relapses were treated with escalation in immunosuppression. One non-compliant patient suffered graft loss while the remaining patients achieved remission. In adjusted logistic regression analysis, PR3 ANCA+ patients were two times (OR 2.19, p = 0.71) more likely to experience a relapse compared to MPO ANCA+ patients.

Conclusions

This study demonstrates that PR3 ANCA+ patients may be more likely to experience relapse post-transplant. Further investigation of the predictors of vasculitis relapse among AAV patients who are ANCA+ at the time of RTx needs to be pursued.
Literatur
1.
Zurück zum Zitat Booth AD, Pusey CD, Jayne DR (2004) Renal vasculitis—an update in 2004. Nephrol Dial Transpl 19(8):1964–1968CrossRef Booth AD, Pusey CD, Jayne DR (2004) Renal vasculitis—an update in 2004. Nephrol Dial Transpl 19(8):1964–1968CrossRef
2.
Zurück zum Zitat de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17(8):2264–2274 de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17(8):2264–2274
3.
Zurück zum Zitat Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transpl 19(6):1403–1411CrossRef Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transpl 19(6):1403–1411CrossRef
4.
Zurück zum Zitat Allen A, Pusey C, Gaskin G (1998) Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 9(7):1258–1263PubMed Allen A, Pusey C, Gaskin G (1998) Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 9(7):1258–1263PubMed
5.
Zurück zum Zitat Hruskova Z, Geetha D, Tesar V (2015) Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transpl 30(Suppl 1):i159–i163 Hruskova Z, Geetha D, Tesar V (2015) Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transpl 30(Suppl 1):i159–i163
6.
Zurück zum Zitat Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N et al (2013) The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J Am Soc Nephrol 8(5):773–780CrossRefPubMedPubMedCentral Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N et al (2013) The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J Am Soc Nephrol 8(5):773–780CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Hruskova Z, Stel VS, Jayne D, Aasarod K, De Meester J, Ekstrand A et al (2015) Characteristics and outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European renal association-european dialysis and transplant association registry. Am J Kidney Dis 66(4):613–620CrossRefPubMed Hruskova Z, Stel VS, Jayne D, Aasarod K, De Meester J, Ekstrand A et al (2015) Characteristics and outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European renal association-european dialysis and transplant association registry. Am J Kidney Dis 66(4):613–620CrossRefPubMed
8.
Zurück zum Zitat Geetha D, Eirin A, True K, Valentina Irazabal M, Specks U, Seo P et al (2011) Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience. Transplantation 91(12):1370–1375CrossRefPubMedPubMedCentral Geetha D, Eirin A, True K, Valentina Irazabal M, Specks U, Seo P et al (2011) Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience. Transplantation 91(12):1370–1375CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Gera M, Griffin MD, Specks U, Leung N, Stegall MD, Fervenza FC (2007) Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Kidney Int 71(12):1296–1301CrossRefPubMed Gera M, Griffin MD, Specks U, Leung N, Stegall MD, Fervenza FC (2007) Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Kidney Int 71(12):1296–1301CrossRefPubMed
10.
Zurück zum Zitat Moroni G, Torri A, Gallelli B, Quaglini S, Pozzi C, Banfi G et al (2007) The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transpl 7(9):2133–2139CrossRef Moroni G, Torri A, Gallelli B, Quaglini S, Pozzi C, Banfi G et al (2007) The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transpl 7(9):2133–2139CrossRef
11.
Zurück zum Zitat Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis 62(3):403–441CrossRefPubMed Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis 62(3):403–441CrossRefPubMed
12.
Zurück zum Zitat Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D et al (2005) Canadian society of transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ 173(10):S1–S25CrossRefPubMedPubMedCentral Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D et al (2005) Canadian society of transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ 173(10):S1–S25CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA (2006) Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxford) 45(6):724–729CrossRef Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA (2006) Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxford) 45(6):724–729CrossRef
14.
Zurück zum Zitat Nachman PH, Segelmark M, Westman K, Hogan SL, Satterly KK, Jennette JC et al (1999) Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 56(4):1544–1550CrossRefPubMed Nachman PH, Segelmark M, Westman K, Hogan SL, Satterly KK, Jennette JC et al (1999) Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 56(4):1544–1550CrossRefPubMed
15.
Zurück zum Zitat Marco H, Mirapeix E, Arcos E, Comas J, Ara J, Gil-Vernet S et al (2013) Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation. Clin Transplant 27(3):338–347CrossRefPubMed Marco H, Mirapeix E, Arcos E, Comas J, Ara J, Gil-Vernet S et al (2013) Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation. Clin Transplant 27(3):338–347CrossRefPubMed
16.
Zurück zum Zitat Little MA, Hassan B, Jacques S, Game D, Salisbury E, Courtney AE et al (2009) Renal transplantation in systemic vasculitis: when is it safe? Nephrol Dial Transpl 24(10):3219–3225CrossRef Little MA, Hassan B, Jacques S, Game D, Salisbury E, Courtney AE et al (2009) Renal transplantation in systemic vasculitis: when is it safe? Nephrol Dial Transpl 24(10):3219–3225CrossRef
17.
Zurück zum Zitat Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187–192CrossRefPubMed Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187–192CrossRefPubMed
18.
Zurück zum Zitat Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33(8):1101–1107CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33(8):1101–1107CrossRefPubMed
19.
Zurück zum Zitat Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347(2):103–109CrossRefPubMed Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347(2):103–109CrossRefPubMed
20.
Zurück zum Zitat Moran S, Little MA (2014) Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Rheumatol 26(1):37–41CrossRefPubMed Moran S, Little MA (2014) Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Rheumatol 26(1):37–41CrossRefPubMed
21.
Zurück zum Zitat Walsh M, Flossmann O, Berden A, Westman K, Hoglund P, Stegeman C et al (2012) Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64(2):542–548CrossRefPubMed Walsh M, Flossmann O, Berden A, Westman K, Hoglund P, Stegeman C et al (2012) Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64(2):542–548CrossRefPubMed
22.
Zurück zum Zitat Reaich D, Cooper N, Main J (1994) Rapid catastrophic onset of Wegener’s granulomatosis in a renal transplant. Nephron 67(3):354–357CrossRefPubMed Reaich D, Cooper N, Main J (1994) Rapid catastrophic onset of Wegener’s granulomatosis in a renal transplant. Nephron 67(3):354–357CrossRefPubMed
23.
Zurück zum Zitat Fan SL, Lewis KE, Ball E, Dodd S, Raftery MJ, Yaqoob MM (2001) Recurrence of Wegener’s granulomatosis 13 years after renal transplantation. Am J Kidney Dis 38(6):E32CrossRefPubMed Fan SL, Lewis KE, Ball E, Dodd S, Raftery MJ, Yaqoob MM (2001) Recurrence of Wegener’s granulomatosis 13 years after renal transplantation. Am J Kidney Dis 38(6):E32CrossRefPubMed
24.
Zurück zum Zitat Gomez-Puerta JA, Bosch X (2009) Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update. Am J Pathol 175(5):1790–1798CrossRefPubMedPubMedCentral Gomez-Puerta JA, Bosch X (2009) Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update. Am J Pathol 175(5):1790–1798CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA et al (2007) ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am J Med 120(7):643 e9–e14 Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA et al (2007) ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am J Med 120(7):643 e9–e14
26.
Zurück zum Zitat Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA (2012) Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis. Rheumatology (Oxford) 51(1):100–109CrossRef Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA (2012) Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis. Rheumatology (Oxford) 51(1):100–109CrossRef
27.
Zurück zum Zitat Nowack R, Grab I, Flores-Suarez LF, Schnulle P, Yard B, van der Woude FJ (2001) ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transpl 16(8):1631–1637CrossRef Nowack R, Grab I, Flores-Suarez LF, Schnulle P, Yard B, van der Woude FJ (2001) ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transpl 16(8):1631–1637CrossRef
28.
Zurück zum Zitat Fussner LA, Specks U (2015) Can antineutrophil cytoplasmic antibody levels be used to inform treatment of pauci-immune vasculitis? Curr Opin Rheumatol 27(3):231–240CrossRefPubMed Fussner LA, Specks U (2015) Can antineutrophil cytoplasmic antibody levels be used to inform treatment of pauci-immune vasculitis? Curr Opin Rheumatol 27(3):231–240CrossRefPubMed
29.
Zurück zum Zitat Rostaing L, Modesto A, Oksman F, Cisterne JM, Le Mao G, Durand D (1997) Outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. Am J Kidney Dis 29(1):96–102CrossRefPubMed Rostaing L, Modesto A, Oksman F, Cisterne JM, Le Mao G, Durand D (1997) Outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. Am J Kidney Dis 29(1):96–102CrossRefPubMed
30.
Zurück zum Zitat Deegens JK, Artz MA, Hoitsma AJ, Wetzels JF (2003) Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease. Clin Nephrol 59(1):1–9CrossRefPubMed Deegens JK, Artz MA, Hoitsma AJ, Wetzels JF (2003) Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease. Clin Nephrol 59(1):1–9CrossRefPubMed
31.
Zurück zum Zitat Cao Y, Tian Z, Li W, Ma L, Yu Y, Ren W (2014) Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease. J Rheumatol 41(5):916–922CrossRefPubMed Cao Y, Tian Z, Li W, Ma L, Yu Y, Ren W (2014) Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease. J Rheumatol 41(5):916–922CrossRefPubMed
32.
Zurück zum Zitat Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC et al (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143(9):621–631CrossRefPubMed Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC et al (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143(9):621–631CrossRefPubMed
33.
Zurück zum Zitat Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214–223CrossRefPubMedPubMedCentral Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214–223CrossRefPubMedPubMedCentral
Metadaten
Titel
Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis
verfasst von
Duvuru Geetha
Scott M. Lee
Shivani Shah
Hafizur M. Rahman
Publikationsdatum
01.02.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 1/2017
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-015-0253-6

Weitere Artikel der Ausgabe 1/2017

Journal of Nephrology 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.